Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Instructions to Pick the Best Course for Your Next Waterway Voyage: Objections, Views, and Social Encounters - 2Grasping the Course of Evacuation and Extradition in U.S. Migration
- 3Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
- 4This Huge Ocean Beast Shifts Sharks’ Evolutionary Timeline
- 5Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers
- The Force of Care: Living with Goal
- How Google, Microsoft, Walmart, and other corporate giants are preparing for an aging workforce
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- Artemis 2 astronauts arrive at Kennedy Space Center ahead of NASA's historic launch around the moon
- 7 Powerful Methods for forestalling Telephone Overheating: Keep Your Gadget Cool
- Famous Versatile Brands: Your Decision
- Damaged launch pad: How long before Russia can send astronauts to the ISS again?
- Man triggers smoke bomb during failed crypto robbery
